Compounds > lenalidomide
Page last updated: 2024-09-05

lenalidomide and Aplasia Pure Red Cell

lenalidomide has been researched along with Aplasia Pure Red Cell in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alfinito, F; Avilia, S; Catalano, L; Cerchione, C; Cerciello, G; Pane, F; Picardi, M; Pisano, I; Risitano, AM1
Childs, R; Costello, R; Korde, N; Kwok, M; Landgren, O; Loeliger, K; Maric, I; Mo, C; Noel, P; Poon, A; Silver, S; Simakova, O; Sloand, E; Young, N; Zhang, Y; Zingone, A1

Other Studies

2 other study(ies) available for lenalidomide and Aplasia Pure Red Cell

ArticleYear
Role of lenalidomide in the management of myelodysplastic syndromes with del(5q) associated with pure red cell aplasia (PRCA).
    Annals of hematology, 2015, Volume: 94, Issue:3

    Topics: Adult; Aged; Chromosome Deletion; Chromosomes, Human, Pair 5; Female; Humans; Lenalidomide; Male; Middle Aged; Myelodysplastic Syndromes; Red-Cell Aplasia, Pure; Thalidomide

2015
Monoclonal gammopathy-associated pure red cell aplasia.
    British journal of haematology, 2016, Volume: 173, Issue:6

    Topics: Adult; Aged; Bone Marrow; Dexamethasone; Diagnosis, Differential; Female; Humans; Immunoglobulins; Lenalidomide; Male; Middle Aged; Multiple Myeloma; Paraproteinemias; Plasma Cells; Red-Cell Aplasia, Pure; Reticulocyte Count; Reticulocytes; Thalidomide; Young Adult

2016